556
Participants
Start Date
December 11, 2014
Primary Completion Date
June 10, 2016
Study Completion Date
June 10, 2016
Mepolizumab
Humanised Immunoglobulin G (IgG) antibody (IgG1, kappa) with human heavy and light chain frameworks, provided as a lyophilised cake in sterile vial. Vial to be reconstituted with sterile water for injection, just prior to use
Placebo
Sterile 0.9% sodium chloride solution
SOC
Standard of Care (SOC) will differ by participants, however it will include high dose ICS with at least one other controller, e.g. LABA, with or without maintenance OCS
GSK Investigational Site, Brussels
GSK Investigational Site, Sofia
GSK Investigational Site, La Plata
GSK Investigational Site, Rosario
GSK Investigational Site, Leuven
GSK Investigational Site, Concepción del Uruguay
GSK Investigational Site, Liège
GSK Investigational Site, Stavanger
GSK Investigational Site, Bergen
GSK Investigational Site, Erpent
GSK Investigational Site, Mendoza
GSK Investigational Site, San Rafael
GSK Investigational Site, Pleven
GSK Investigational Site, Trondheim
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Ghent
GSK Investigational Site, Berlin
GSK Investigational Site, Athens
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Tallinn
GSK Investigational Site, Tallinn
GSK Investigational Site, Marseille
GSK Investigational Site, Rochester
GSK Investigational Site, Santiago de Compostela
GSK Investigational Site, Upland
GSK Investigational Site, Hamburg
GSK Investigational Site, Vinnytsia
GSK Investigational Site, Vinnytsia
GSK Investigational Site, Dijon
GSK Investigational Site, Baltimore
GSK Investigational Site, Hamburg
GSK Investigational Site, Williamsburg
GSK Investigational Site, Richmond
GSK Investigational Site, Schleswig
GSK Investigational Site, Durham
GSK Investigational Site, Madrid
GSK Investigational Site, Gastonia
GSK Investigational Site, Pozuelo de Alarcón/Madrid
GSK Investigational Site, Alcorcón (Madrid)
GSK Investigational Site, Orangeburg
GSK Investigational Site, Brest
GSK Investigational Site, Orlando
GSK Investigational Site, Aventura
GSK Investigational Site, Pessac
GSK Investigational Site, Montpellier
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Santander
GSK Investigational Site, Reggio Emilia
GSK Investigational Site, Parma
GSK Investigational Site, Nantes
GSK Investigational Site, Cincinnati
GSK Investigational Site, Valencia
GSK Investigational Site, Dnipro
GSK Investigational Site, Florence
GSK Investigational Site, Tartu
GSK Investigational Site, Reims
GSK Investigational Site, Rochester
GSK Investigational Site, Koblenz
GSK Investigational Site, Pisa
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Rapid City
GSK Investigational Site, Witten
GSK Investigational Site, Lille
GSK Investigational Site, Kharkiv
GSK Investigational Site, Kharkiv
GSK Investigational Site, Odesa
GSK Investigational Site, Chieti
GSK Investigational Site, Zaporizhia
GSK Investigational Site, Lyon
GSK Investigational Site, Bari
GSK Investigational Site, Foggia
GSK Investigational Site, Rethymnon, Crete
GSK Investigational Site, Paris
GSK Investigational Site, Denver
GSK Investigational Site, Munich
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Rolling Hills Estates
GSK Investigational Site, Long Beach
GSK Investigational Site, Upland
GSK Investigational Site, Riverside
GSK Investigational Site, Newport Beach
GSK Investigational Site, Fresno
GSK Investigational Site, Bamberg
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petesburg
GSK Investigational Site, Sestroretsk
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Stavropol
GSK Investigational Site, Voronezh
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Novosibirsk
GSK Investigational Site, Irkutsk
GSK Investigational Site, New Haven
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Calgary
GSK Investigational Site, Vancouver
GSK Investigational Site, Winnipeg
GSK Investigational Site, Burlington
GSK Investigational Site, St-Charles-Borromée
GSK Investigational Site, Toronto
GSK Investigational Site, Windsor
GSK Investigational Site, Montreal
GSK Investigational Site, Sainte-Foy
GSK Investigational Site, Trois-Rivières
GSK Investigational Site, Brno
GSK Investigational Site, Hlučín
GSK Investigational Site, Hradec Králové
GSK Investigational Site, Kralupy nad Vltavou
GSK Investigational Site, Olomouc
GSK Investigational Site, Pilsen
GSK Investigational Site, Prague
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Athens
GSK Investigational Site, Haidari / Athens
GSK Investigational Site, Amsterdam
GSK Investigational Site, Breda
GSK Investigational Site, Leeuwarden
GSK Investigational Site, Leiden
GSK Investigational Site, Rotterdam
GSK Investigational Site, Oslo
GSK Investigational Site, Lima
GSK Investigational Site, San Martín de Porres
GSK Investigational Site, San Miguel
GSK Investigational Site, Lima
GSK Investigational Site, Lima
GSK Investigational Site, Bojnice
GSK Investigational Site, Spišská Nová Ves
GSK Investigational Site, Šaľa
GSK Investigational Site, Vráble
GSK Investigational Site, Alicante
GSK Investigational Site, Barcelona
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Bradford
GSK Investigational Site, Oxford
GSK Investigational Site, Plymouth
GSK Investigational Site, Swansea
Lead Sponsor
GlaxoSmithKline
INDUSTRY